Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soluble Urokinase Plasminogen Activation Receptor”

2 trials

Showing 2 of 2 results

Not applicableStudy completedNCT05580016
What this trial is testing

Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.

Who this might be right for
Soluble Urokinase Plasminogen Activation ReceptorAbdominal PainEmergency Department+1 more
Poitiers University Hospital 200
Not applicableStudy completedNCT02643459
What this trial is testing

Risk Stratification in Acute Care: The Meaning of suPAR Measurement in Triage

Who this might be right for
TriageRisk Stratification With Biomarker
Herlev Hospital 20,000

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation